These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15741026)

  • 1. In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma.
    Bourne RM; Stanwell P; Stretch JR; Scolyer RA; Thompson JF; Mountford CE; Lean CL
    Eur J Radiol; 2005 Mar; 53(3):506-13. PubMed ID: 15741026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples.
    Stretch JR; Somorjai R; Bourne R; Hsiao E; Scolyer RA; Dolenko B; Thompson JF; Mountford CE; Lean CL
    Ann Surg Oncol; 2005 Nov; 12(11):943-9. PubMed ID: 16177860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of 8.5 T magnetic resonance spectroscopy of benign and malignant skin lesion biopsies.
    Guitera P; Bourgeat P; Stretch JR; Scolyer RA; Ourselin S; Lean C; Thompson JF; Bourne R
    Melanoma Res; 2010 Aug; 20(4):311-7. PubMed ID: 20626102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
    Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
    NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
    Eyden B; Pandit D; Banerjee SS
    Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer.
    Seenu V; Pavan Kumar MN; Sharma U; Gupta SD; Mehta SN; Jagannathan NR
    Magn Reson Imaging; 2005 Dec; 23(10):1005-10. PubMed ID: 16376185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas.
    Martínez-Bisbal MC; Martí-Bonmatí L; Piquer J; Revert A; Ferrer P; Llácer JL; Piotto M; Assemat O; Celda B
    NMR Biomed; 2004 Jun; 17(4):191-205. PubMed ID: 15229932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens.
    Lean CL; Bourne R; Thompson JF; Scolyer RA; Stretch J; Li LX; Russell P; Mountford C
    Melanoma Res; 2003 Jun; 13(3):259-61. PubMed ID: 12777980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes.
    Kalogeraki A; Garbagnati F; Darivianaki K; Delides GS; Santinami M; Stathopoulos EN; Zoras O
    Anticancer Res; 2006; 26(5A):3551-4. PubMed ID: 17094481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.